Maternal and female fetal testosterone levels are associated with maternal age and gestational weight gain
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Objective: Prenatal androgen exposure has been suggested to play a role in polycystic ovary syndrome. Given the limited information on what maternal characteristics influence maternal testosterone levels, and the even less explored routes by which female fetus androgen exposure would occur, the aim of this study was to investigate the impact of maternal age, BMI, weight gain, depressed mood and aromatase SNPs on testosterone levels in maternal serum and amniotic fluid of female fetuses. Methods: Blood samples from pregnant women (n = 216) obtained in gestational weeks 35–39, and pre-labor amniotic fluid samples from female fetuses (n = 56), taken at planned Caesarean section or in conjunction with amniotomy for induction of labor, were analyzed. Maternal serum testosterone and amniotic fluid testosterone and cortisol were measured by tandem mass spectrometry. Results: Multiparity (β = −0.28,P < 0.001), self-rated depression (β = 0.26,P < 0.001) and weight gain (β = 0.18,P < 0.05) were independent explanatory factors for the maternal total testosterone levels. Maternal age (β = −0.34,P < 0.001), weight gain (β = 0.19,P < 0.05) and amniotic fluid cortisol levels (β = 0.44,P < 0.001) were independent explanatory factors of amniotic fluid testosterone in female fetuses, explaining 64.3% of the variability in amniotic fluid testosterone. Wider implications of the findings: Young maternal age and excessive maternal weight gain may increase the prenatal androgen exposure of female fetuses. Further studies are needed to explore this finding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Currently, the best-known correlates of low amniotic fluid testosterone among female fetuses are young maternal age, low weight gain during pregnancy, and low amniotic fluid cortisol; these factors together account for 64% of variation in testosterone level.85”
From Prenatal Origins of Endometriosis Pathology and Pain: Reviewing the Evidence of a Role for Low Testosterone (2023) · cites this paper as [85]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other maternal factors such as elevated stress, quantified by amniotic cortisol levels, increased maternal weight gain, and young maternal age together predict 64.3% of the variation in amniotic testosterone drawn from female fetuses (Kallak et al., 2017).”
From Endometriosis and polycystic ovary syndrome are diametric disorders (2021) · cites this paper as Kallak et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burger, H. G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02985-0 · Cited by 771 · cited 2×
“In non-pregnant women, 25% of circulating testosterone is derived from the adrenals, 25% from the ovary and the remaining 50% from the peripheral conversion of androstenedione (36).”
Cooney, L. G., Lee, I., Sammel, M. D., & Dokras, A. (2017) · Human Reproduction · doi:10.1093/humrep/dex044 · Cited by 631 · cited 1×
“While women with PCOS more commonly suffer from anxiety and depression, and especially so, if they have high levels of free testosterone (41), there is no proven causality for testosterone in the development and maintenance of depression in women.”
Abbott, D. H., Barnett, D. K., Bruns, C. M., & Dumesic, D. A. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi013 · Cited by 555
(2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70301-2 · Cited by 399
In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development
Goto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25091 · Cited by 284 · cited 2×
“It is assumed that the testosterone detected in amniotic fluid of female fetuses is primarily of adrenal origin, where it is partly regulated by adrenocorticotropic-releasing hormone (ACTH) (27).”
Longitudinal assessment of changes in reproductive hormones during normal pregnancy
O'Leary, P., Boyne, P., Flett, P., Beilby, J., & James, I. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.5.667 · Cited by 277
Sheep models of polycystic ovary syndrome phenotype
Padmanabhan, V., & Veiga-Lopez, A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.005 · Cited by 225
Hines, M. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.02.006 · Cited by 219
Moore, A. M., Prescott, M., Marshall, C. J., Yip, S. H., & Campbell, R. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415038112 · Cited by 217
Self-citationvan de Beek, C., Thijssen, J. H. H., Cohen-Kettenis, P. T., van Goozen, S. H. M., & Buitelaar, J. K. (2004) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.06.010 · Cited by 203 · cited 2×
“In support of this, several studies have been unable to correlate maternal testosterone levels with umbilical cord levels of testosterone (15, 16, 17) or amniotic fluid with umbilical cord levels of testosterone (17).”
Cited by
Role of the Monocyte–Macrophage System in Normal Pregnancy and Preeclampsia
Vishnyakova, P., Elchaninov, A. V., Fatkhudinov, T., & Sukhikh, G. T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153695 · Cited by 112
“As for PE, it has been shown that testosterone level in women with PE is greatly increased [76].”
BackgroundEndometriosis and polycystic ovary syndrome are diametric disorders
Dinsdale, N. L., & Crespi, B. J. (2021) · Evolutionary Applications · doi:10.1111/eva.13244 · Cited by 90
“Maternally produced testosterone enters the placenta, but in typically developing females, most is converted into estrogens via aromatase (Kallak et al., 2017).”
BackgroundInfluentialPostpartum Depression: Current Status and Possible Identification Using Biomarkers
Yu, Y., Liang, H.-F., Chen, J., Li, Z., Han, Y., Chen, J.-X., & Li, J.-C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.620371 · Cited by 113
“Women with PPD symptoms were reported to have higher serum testosterone levels in the late third trimester (136) and around 24 h postpartum than healthy controls (137).”
BackgroundNutritional adversity, sex and reproduction: 30 years of DOHaD and what have we learned?
Jazwiec, P. A., & Sloboda, D. M. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0048 · Cited by 97
Developmental programming of the female reproductive system—a review
Yao, S., López‐Tello, J., & Sferruzzi-Perri, A. N. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa232 · Cited by 75
“Moreover, studies have shown that excess maternal weight gain in pregnancy is associated with increased concentrations of androgens in both maternal blood and fetal amniotic fluid [92], and androgen exposure in utero may in turn lead to an increased the risk of ovarian changes, such as follicular cysts [93].”
Background
Metadata
- Authors
- Kallak, T. K., Hellgren, C., Skalkidou, A., Sandelin-Francke, L., Ubhayasekhera, K., Bergquist, J., Axelsson, O., Comasco, E., Campbell, R. E., & Sundström Poromaa, I.
- Affiliations
- 1Departments of Women’s and Children’s Health
- Uppsala University (SE)
- University of Otago (NZ)
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10
- Volume
- 177
- Issue
- 4
- Pages
- 379-388
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- PMC
- PMC5597951
- OpenAlex
- W2734757017
- Cited by
- 70
- References
- 43
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 6 · 2023: 10 · 2022: 5 · 2021: 12 · 2020: 9 · 2019: 13 · 2018: 6
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- European Journal of Endocrinology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- Funders
- Fredrik och Ingrid Thurings Stiftelse
- Vetenskapsrådet (2015-04870, 523-2014-2342, INCA 600398, 2015-00495)
- Landstinget Sörmland
- Institut National Du Cancer (600398)
- Uppsala Universitet
- Svenska Läkaresällskapet (SLS‐331991, 2015-00495)
- Marcus och Amalia Wallenbergs minnesfond
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- prenatal androgen exposure, maternal testosterone, fetal testosterone, maternal age, gestational weight gain, maternal depression, multiparity, maternal body mass index, polycystic ovary syndrome, female fetus
- MeSH terms
- Adult, Amniotic Fluid, Depression, Female, Fetus, Humans, Maternal Age, Pregnancy, Pregnancy Complications, Sweden, Testosterone, Cohort Studies, Weight Gain, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Maternal and female fetal testosterone levels are associated with maternal age and gestational weight gain. https://app.cochat.ai/papers/10.1530/eje-17-0207
- The paper
- Kallak, T. K., Hellgren, C., Skalkidou, A., Sandelin-Francke, L., Ubhayasekhera, K., Bergquist, J., Axelsson, O., Comasco, E., Campbell, R. E., & Sundström Poromaa, I. (2017). Maternal and female fetal testosterone levels are associated with maternal age and gestational weight gain. European Journal of Endocrinology. https://doi.org/10.1530/eje-17-0207
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.